The discovery of novel targets often presents opportunities to create highly successful classes of anticancer drugs. A prime example is the PD-1/PD-L1 inhibitor class, which achieved total global sales of $55 billion in 2024. Among them, the first-in-class product,
Subscribe to Creative Biogene Blog’s news feed.
Click on “Follow” and decide if you want to get news from Creative Biogene Blog via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Creative Biogene Blog comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Creative Biogene Blog which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Transfected Stable Cell Lines, Custom Viral Service, Gene Editing - Creative Biogene